A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
NCT06296966 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-03-06
Summary
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Conditions
- Dry Eye
Interventions
- DRUG
-
VSJ-110
ophthalmic solution
- DRUG
-
ophthalmic solution
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-29
- Primary Completion
- 2024-07-31
- Completion
- 2024-07-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
NCT01558999 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
NCT06493604 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
NCT04092907 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
NCT02965846 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye
NCT04268069 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
NCT05411367 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
NCT00037661 ·Status: COMPLETED ·Phase: PHASE3
-
Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT05370495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome
NCT04206020 ·Status: COMPLETED ·Phase: PHASE3
-
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye
NCT06696625 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
NCT01239069 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
Study of ST-100 as Treatment for Dry Eye Disease
NCT05241470 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
NCT01960010 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.
NCT03723811 ·Status: COMPLETED ·Phase: PHASE2
-
Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease
NCT06360133 ·Status: RECRUITING ·Phase: PHASE3
-
Study of TOP1630 for Dry Eye Syndrome
NCT03833388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of VVN001 Ophthalmic Solution in Dry Eye Disease
NCT04556838 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease
NCT03414645 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
NCT01257607 ·Status: COMPLETED ·Phase: PHASE2